KPJ Healthcare Berhad’s financial performance for the third quarter ended 30 September 2025 (Q3 FY2025) delivered steady performance with continued growth in revenue and earnings. This was supported by sustained patient activity, stronger case mix and ongoing efforts to enhance service capacity and operational efficiency.

The Group recorded a 9% increase in revenue to RM1,116 million from RM1,027.6 million in the corresponding quarter last year. This growth was supported by patient growth and higher surgical volume. Patient visits increased 4% compared with the corresponding quarter ended 30 September 2024, while surgeries rose 7%, reflecting stronger demand for complex procedures and specialised services.

Profit before tax rose 9% to RM151.9 million, while EBITDA increased 8% to RM274 million. These results reflect the Group’s sustained operational focus, stronger case mix and disciplined cost management, even with expanded capacity across the Group.

PATAMI increased 9% to RM94 million. This was driven by stronger revenue and continued focus on efficient operations, with overall profitability supported by improved revenue intensity.

For the quarter, inpatient admissions were sustained at 100,001, compared to the corresponding quarter last year. Outpatient visits increased to 766,516, while bed occupancy rate stood at 66%.

The Group declared an interim dividend of 1.23 sen per share, totalling RM53.7 million, payable on 23 December 2025.

Chin Keat Chyuan, President and Managing Director of KPJ Healthcare said, “We continue to deliver a solid third-quarter performance, made possible by the trust placed in us, especially by our patients. Group revenue rose 9% year on year to RM1,116 million, supported by patient activity and higher surgical volume. PATAMI increased 9% to RM94 million, while EBITDA grew 8% to RM274 million. PATAMI and EBITDA improved, while gross profit margin eased slightly due to mix effects.

Growth this quarter was driven by stronger case mix and a higher number of complex procedures. Surgeries increased 7% year on year and outpatient volumes also improved. While additional capacity moderated bed occupancy, average revenue per inpatient increased, highlighting stronger demand for specialised care.

Since beginning our transformation in 2023, we remain focused on strengthening Malaysia as our core platform and optimising our portfolio, building a resilient foundation for sustainable growth.

Under the KPJ Health System, we continue to deepen subspecialty capabilities, advance digital initiatives and develop the capabilities required to support future Centres of Excellence. As we take a long-term view, we remain committed to providing care that is accessible, sustainable and centred on the people we serve.”

KPJ Healthcare remains cautiously optimistic about its prospects for the financial year 2025, supported by sustained patient demand and its ongoing efforts to improve operational efficiency. These include asset optimisation, capacity expansion and disciplined cost management.

Bank Negara Malaysia reported GDP growth of 5.2% for the third quarter of 2025 and maintained a full-year GDP forecast of between 4.0% and 4.8%. The Ministry of Health’s decision to defer the implementation of the Diagnosis Related Group (DRG) system to 2027 also provides added clarity for a smoother, more sustainable transition.

This content is provided by KPJ healthcare

The views expressed here are those of the author/contributor and do not necessarily represent the views of Malaysiakini.

Interested in having your press releases, exclusive interviews, or branded content articles on Malaysiakini? For more information, contact [email protected] or [email protected]